Shear wave elastography predicts hepatocellular carcinoma risk in hepatitis C patients after sustained virological response

被引:20
作者
Hamada, Koichi [1 ,2 ]
Saitoh, Satoshi [3 ]
Nishino, Noriyuki [1 ]
Fukushima, Daizo [1 ]
Horikawa, Yoshinori [1 ]
Nishida, Shinya [2 ]
Honda, Michitaka [1 ,2 ]
机构
[1] Fukushima Med Univ, Dept Minimally Invas Surg & Med Oncol, Fukushima, Japan
[2] Southern Tohoku Gen Hosp, Dept Gastroenterol, Koriyama, Fukushima, Japan
[3] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan
来源
PLOS ONE | 2018年 / 13卷 / 04期
关键词
LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; NONINVASIVE EVALUATION; INTERFERON THERAPY; LONG-TERM; STIFFNESS; SCORE;
D O I
10.1371/journal.pone.0195173
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aim To evaluate the relationship between fibrosis and HCC after sustained virological response (SVR) to treatment for chronic hepatitis C (HCV). Methods This single-center study retrospectively evaluated 196 patients who achieved SVR after HCV infection. The associations of risk factors with HCC development after HCV eradication were evaluated using univariate and multivariate Cox proportional hazards regression models. Results Among the 196 patients, 8 patients (4.1%) developed HCC after SVR during a median follow-up of 26 months. Multivariate analyses revealed that HCC development was independently associated with age of >= 75 years (risk ratio [RR] = 35.16), alpha-fetoprotein levels of >= 6 ng/mL (RR = 40.30), and SWE results of >= 11 kPa (RR = 28.71). Conclusions Our findings indicate that SWE may facilitate HCC surveillance after SVR and the identification of patients who have an increased risk of HCC after HCV clearance.
引用
收藏
页数:11
相关论文
共 28 条
  • [1] A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C-Associated Liver Cirrhosis
    Aleman, Soo
    Rahbin, Nogol
    Weiland, Ola
    Davidsdottir, Loa
    Hedenstierna, Magnus
    Rose, Nina
    Verbaan, Hans
    Stal, Per
    Carlsson, Tony
    Norrgren, Hans
    Ekbom, Anders
    Granath, Fredrik
    Hultcrantz, Rolf
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 (02) : 230 - 236
  • [2] Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C
    Arima, Yuko
    Kawabe, Naoto
    Hashimoto, Senju
    Harata, Masao
    Nitta, Yoshifumi
    Murao, Michihito
    Nakano, Takuji
    Shimazaki, Hiroaki
    Kobayashi, Kyoko
    Ichino, Naohiro
    Osakabe, Keisuke
    Nishikawa, Toru
    Okumura, Akihiko
    Ishikawa, Tetsuya
    Yoshioka, Kentaro
    [J]. HEPATOLOGY RESEARCH, 2010, 40 (04) : 383 - 392
  • [3] α-Fetoprotein Levels After Interferon Therapy and Risk of Hepatocarcinogenesis in Chronic Hepatitis C
    Asahina, Yasuhiro
    Tsuchiya, Kaoru
    Nishimura, Takashi
    Muraoka, Masaru
    Suzuki, Yuichiro
    Tamaki, Nobuharu
    Yasui, Yutaka
    Hosokawa, Takanori
    Ueda, Ken
    Nakanishi, Hiroyuki
    Itakura, Jun
    Takahashi, Yuka
    Kurosaki, Masayuki
    Enomoto, Nobuyuki
    Nakagawa, Mina
    Kakinuma, Sei
    Watanabe, Mamoru
    Izumi, Namiki
    [J]. HEPATOLOGY, 2013, 58 (04) : 1253 - 1262
  • [4] Effect of Aging on Risk for Hepatocellular Carcinoma in Chronic Hepatitis C Virus Infection
    Asahina, Yasuhiro
    Tsuchiya, Kaoru
    Tamaki, Nobuharu
    Hirayama, Itsuko
    Tanaka, Tomohiro
    Sato, Mitsuaki
    Yasui, Yutaka
    Hosokawa, Takanori
    Ueda, Ken
    Kuzuya, Teiji
    Nakanishi, Hiroyuki
    Itakura, Jun
    Takahashi, Yuka
    Kurosaki, Masayuki
    Enomoto, Nobuyuki
    Izumi, Namiki
    [J]. HEPATOLOGY, 2010, 52 (02) : 518 - 527
  • [5] NONINVASIVE IN VIVO LIVER FIBROSIS EVALUATION USING SUPERSONIC SHEAR IMAGING: A CLINICAL STUDY ON 113 HEPATITIS C VIRUS PATIENTS
    Bavu, Eric
    Gennisson, Jean-Luc
    Couade, Mathieu
    Bercoff, Jeremy
    Mallet, Vincent
    Fink, Mathias
    Badel, Anne
    Vallet-Pichard, Anais
    Nalpas, Bertrand
    Tanter, Mickael
    Pol, Stanislas
    [J]. ULTRASOUND IN MEDICINE AND BIOLOGY, 2011, 37 (09) : 1361 - 1373
  • [6] The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update
    El-Serag, H
    Davila, JA
    Petersen, NJ
    McGlynn, KA
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (10) : 817 - 823
  • [7] Accuracy of Real-Time Shear Wave Elastography for Assessing Liver Fibrosis in Chronic Hepatitis C: A Pilot Study
    Ferraioli, Giovanna
    Tinelli, Carmine
    Dal Bello, Barbara
    Zicchetti, Mabel
    Filice, Gaetano
    Filice, Carlo
    [J]. HEPATOLOGY, 2012, 56 (06) : 2125 - 2133
  • [8] Liver stiffness diminishes with antiviral response in chronic hepatitis C
    Hezode, C.
    Castera, L.
    Roudot-Thoraval, F.
    Bouvier-Alias, M.
    Rosa, I.
    Roulot, D.
    Leroy, V.
    Mallat, A.
    Pawlotsky, J. -M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (06) : 656 - 663
  • [9] Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis
    Ikeda, K
    Saitoh, S
    Arase, Y
    Chayama, K
    Suzuki, Y
    Kobayashi, M
    Tsubota, A
    Kobayashi, M
    Nakamura, I
    Murashima, N
    Kumada, H
    Kawanishi, M
    [J]. HEPATOLOGY, 1999, 29 (04) : 1124 - 1130
  • [10] Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
    Ikeda, M
    Fujiyama, S
    Tanaka, M
    Sata, M
    Ide, T
    Yatsuhashi, H
    Watanabe, H
    [J]. JOURNAL OF GASTROENTEROLOGY, 2005, 40 (02) : 148 - 156